Lecture Title: Peri-operative Fluid Therapy and Blood Transfusion Practice
description
Transcript of Lecture Title: Peri-operative Fluid Therapy and Blood Transfusion Practice
![Page 1: Lecture Title: Peri-operative Fluid Therapy and Blood Transfusion Practice](https://reader035.fdocuments.us/reader035/viewer/2022062803/56814674550346895db39937/html5/thumbnails/1.jpg)
Lecture Title:Lecture Title:Peri-operative Fluid Therapy and Blood Transfusion Practice
Lecturer name: A. DawlatlyLecturer name: A. DawlatlyE-Mail: [email protected]: [email protected] Date: 12/01/1433Lecture Date: 12/01/1433
![Page 2: Lecture Title: Peri-operative Fluid Therapy and Blood Transfusion Practice](https://reader035.fdocuments.us/reader035/viewer/2022062803/56814674550346895db39937/html5/thumbnails/2.jpg)
Model for volume distribution
![Page 3: Lecture Title: Peri-operative Fluid Therapy and Blood Transfusion Practice](https://reader035.fdocuments.us/reader035/viewer/2022062803/56814674550346895db39937/html5/thumbnails/3.jpg)
![Page 4: Lecture Title: Peri-operative Fluid Therapy and Blood Transfusion Practice](https://reader035.fdocuments.us/reader035/viewer/2022062803/56814674550346895db39937/html5/thumbnails/4.jpg)
Response of CVP/PAOP to increase in intra-vascular volume
![Page 5: Lecture Title: Peri-operative Fluid Therapy and Blood Transfusion Practice](https://reader035.fdocuments.us/reader035/viewer/2022062803/56814674550346895db39937/html5/thumbnails/5.jpg)
![Page 6: Lecture Title: Peri-operative Fluid Therapy and Blood Transfusion Practice](https://reader035.fdocuments.us/reader035/viewer/2022062803/56814674550346895db39937/html5/thumbnails/6.jpg)
Stroke volume response to an increased intravascular volume (Frank-Starling curve)
![Page 7: Lecture Title: Peri-operative Fluid Therapy and Blood Transfusion Practice](https://reader035.fdocuments.us/reader035/viewer/2022062803/56814674550346895db39937/html5/thumbnails/7.jpg)
![Page 8: Lecture Title: Peri-operative Fluid Therapy and Blood Transfusion Practice](https://reader035.fdocuments.us/reader035/viewer/2022062803/56814674550346895db39937/html5/thumbnails/8.jpg)
Lecture ObjectivesLecture Objectives
Students at the end of the lecture will be able
to:
-Describe different fluids components
-Describe the challenges of Fluid therapy
-Answer FAQ
![Page 9: Lecture Title: Peri-operative Fluid Therapy and Blood Transfusion Practice](https://reader035.fdocuments.us/reader035/viewer/2022062803/56814674550346895db39937/html5/thumbnails/9.jpg)
FAQs
-Crystalloids vs Colloids
-Role of plasma volume expander in septic shock
-Why dose limit for colloids
-For how long HES
-Does HES reduce capillary leak
-Renal and liver functions
![Page 10: Lecture Title: Peri-operative Fluid Therapy and Blood Transfusion Practice](https://reader035.fdocuments.us/reader035/viewer/2022062803/56814674550346895db39937/html5/thumbnails/10.jpg)
FLUID LOSSES
-TRAUMA
-BURNS
-PERITONITIS
-BLEEDING
![Page 11: Lecture Title: Peri-operative Fluid Therapy and Blood Transfusion Practice](https://reader035.fdocuments.us/reader035/viewer/2022062803/56814674550346895db39937/html5/thumbnails/11.jpg)
Final Goals of Fluid resuscitation
-Achievement of normovolemia& hemodynamic stability-Correction of major acid-base disturbances-Compensation of internal fluid fluxes-Maintain an adequate gradient between COP&PCWP-Improvement of microvascular blood flow-Prevention of cascade system activation-Normalization of O2 delivery-Prevention of reperfusion cellular injury-Achievement of adequate urine output
![Page 12: Lecture Title: Peri-operative Fluid Therapy and Blood Transfusion Practice](https://reader035.fdocuments.us/reader035/viewer/2022062803/56814674550346895db39937/html5/thumbnails/12.jpg)
Desirable outcome of fluid resuscitation
- No peripheral edema
- No ARDS
![Page 13: Lecture Title: Peri-operative Fluid Therapy and Blood Transfusion Practice](https://reader035.fdocuments.us/reader035/viewer/2022062803/56814674550346895db39937/html5/thumbnails/13.jpg)
Undesirable PMN-EC interaction
Activation
Degranulation
Elastase&O2 radicals
EC damage (lysis & detachment)
Leak
![Page 14: Lecture Title: Peri-operative Fluid Therapy and Blood Transfusion Practice](https://reader035.fdocuments.us/reader035/viewer/2022062803/56814674550346895db39937/html5/thumbnails/14.jpg)
Characteristics of different volume substitutes
-IVVP Cryst<Gel<Dex<HSS
-Coag Cryst<Alb<Gel=HES<Dex
-Anaphyl Cryst<HES=Alb<Dex<Gel
-Cost Cryst=Gel<HES<Dex<Alb
![Page 15: Lecture Title: Peri-operative Fluid Therapy and Blood Transfusion Practice](https://reader035.fdocuments.us/reader035/viewer/2022062803/56814674550346895db39937/html5/thumbnails/15.jpg)
Crystalloids in traumaAdvantages:
-Balanced electrolyte solutions
-Buffering capacity (Lactate)
-Easy to administer
-No risk of adverse reactions
-No disturbance of hemostasis
-Promote diuresis
-Inexpensive
![Page 16: Lecture Title: Peri-operative Fluid Therapy and Blood Transfusion Practice](https://reader035.fdocuments.us/reader035/viewer/2022062803/56814674550346895db39937/html5/thumbnails/16.jpg)
Crystalloids contin…Disadvantages:
-Poor plasma volume support
-Large quantities needed
-Risk of Hypothermia
-Reduced plasma COP
-Risk of edema
![Page 17: Lecture Title: Peri-operative Fluid Therapy and Blood Transfusion Practice](https://reader035.fdocuments.us/reader035/viewer/2022062803/56814674550346895db39937/html5/thumbnails/17.jpg)
Crystalloid solutionsNaCl
Isotonic 0.9%: 9g/l , Na 154, Cl 154, Osmolarity: 304mosmol/l Disadvantages: Hyper-chloremic acidosis
![Page 18: Lecture Title: Peri-operative Fluid Therapy and Blood Transfusion Practice](https://reader035.fdocuments.us/reader035/viewer/2022062803/56814674550346895db39937/html5/thumbnails/18.jpg)
Hypertonic saline
Advantages:-Small volume for resuscitation. -Osmotic effect-Inotropic effect-Direct vasodilator effect-Increase MAP, CO-Increase renal, mesenteric,splanchnic, coronary blood flow.Disadvantages: increase hemorrhage from open vessels. HypernatremiaHyperchloremia. Metabolic acidosis.
![Page 19: Lecture Title: Peri-operative Fluid Therapy and Blood Transfusion Practice](https://reader035.fdocuments.us/reader035/viewer/2022062803/56814674550346895db39937/html5/thumbnails/19.jpg)
CrystalloidsLactated Ringer's
Composition: Na 130, cl 109, K 4, ca 3, Lactate 28, Osmolarity 273mosmol/l
-Sydney Ringer 1880-Hartmann added Lactate=LR-Minor advantage over NaClDisadvantages: -Not to be used as diluent for blood (Ca citrate)-Low osmolarity, can lead to high ICP
![Page 20: Lecture Title: Peri-operative Fluid Therapy and Blood Transfusion Practice](https://reader035.fdocuments.us/reader035/viewer/2022062803/56814674550346895db39937/html5/thumbnails/20.jpg)
CrystalloidsDextrose 5%
Composition: 50g/l, provides 170kcal/l
Disadvantages:-enhance CO2 production-enhance lactate production-aggravate ischemic brain injury
![Page 21: Lecture Title: Peri-operative Fluid Therapy and Blood Transfusion Practice](https://reader035.fdocuments.us/reader035/viewer/2022062803/56814674550346895db39937/html5/thumbnails/21.jpg)
Colloids
Advantages:-Good IVVP-Prolonged plasma volume support-Moderate volume needed-minimal risk of tissue edema-enhances microvascular flow
![Page 22: Lecture Title: Peri-operative Fluid Therapy and Blood Transfusion Practice](https://reader035.fdocuments.us/reader035/viewer/2022062803/56814674550346895db39937/html5/thumbnails/22.jpg)
Colloids
Disadvantages:-Risk of volume overload-Adverse effect on hemostasis-Adverse effect on renal function-Anaphylactic reaction-Expensive
![Page 23: Lecture Title: Peri-operative Fluid Therapy and Blood Transfusion Practice](https://reader035.fdocuments.us/reader035/viewer/2022062803/56814674550346895db39937/html5/thumbnails/23.jpg)
Dextran
Composition: 40/70
Inhibit platelet aggregation
bleeding
![Page 24: Lecture Title: Peri-operative Fluid Therapy and Blood Transfusion Practice](https://reader035.fdocuments.us/reader035/viewer/2022062803/56814674550346895db39937/html5/thumbnails/24.jpg)
MRI sagittal view: epid hematoma T12-T9
MRI Transverse view: epid hematoma at T12
Medscape 16/09/03
MRI sagittal view: epid hematoma T12-T9
MRI Transverse view: epid hematoma at T12
Medscape 16/09/03
![Page 25: Lecture Title: Peri-operative Fluid Therapy and Blood Transfusion Practice](https://reader035.fdocuments.us/reader035/viewer/2022062803/56814674550346895db39937/html5/thumbnails/25.jpg)
Gelatins
-Derived from hydrolyzed bovine collagen-Metabolized by serum collagenase-0.5-5hr-Histamine release (H1 blockers recommended)-Decreases Von W factor (VWF)-Bovine Spongiform Encephalopathy
1:1,000.000
![Page 26: Lecture Title: Peri-operative Fluid Therapy and Blood Transfusion Practice](https://reader035.fdocuments.us/reader035/viewer/2022062803/56814674550346895db39937/html5/thumbnails/26.jpg)
Albumins
-Heat treated preparation of human serum-5% (50g/l), 25% (250g/l)-Half of infused volume will stay intravascular -COP=20mmHg=plasma-25%, COP=70mmHg, it will expand the vascular space by 4-5 times the volume infused-25% used only in case of hypoalbuminemia
![Page 27: Lecture Title: Peri-operative Fluid Therapy and Blood Transfusion Practice](https://reader035.fdocuments.us/reader035/viewer/2022062803/56814674550346895db39937/html5/thumbnails/27.jpg)
Cochrane studies support mortality following albumin infusion
- Cardiac decompensation after rapid infusion of 20-25% albumin
- Ionized ca++- Aggravate leak syndrome MOF- Enhance bleeding - Impaired Na+Water excretion renal dysfunction
![Page 28: Lecture Title: Peri-operative Fluid Therapy and Blood Transfusion Practice](https://reader035.fdocuments.us/reader035/viewer/2022062803/56814674550346895db39937/html5/thumbnails/28.jpg)
Hetastarch 6%
Composition: synthetic colloid, 6% preparation in isotonic saline MW 240,000 D- DS 0.7
Advantages: low cost, more potent than 5% albumin (COP 30)
Disadvantages: Hyperamylesemia, allergy, coagulopathyDose: 15-30ml/kg/day
![Page 29: Lecture Title: Peri-operative Fluid Therapy and Blood Transfusion Practice](https://reader035.fdocuments.us/reader035/viewer/2022062803/56814674550346895db39937/html5/thumbnails/29.jpg)
Pentastarch 10%
-MW: 200,000 D- DS 0.5-Low cost-Extensive clinical use in sepsis, burns..-Low permeability index-Good clinical safety-Decreases PMN-EC activation-Potential to diminish vascular permeability and reduces tissue edema
![Page 30: Lecture Title: Peri-operative Fluid Therapy and Blood Transfusion Practice](https://reader035.fdocuments.us/reader035/viewer/2022062803/56814674550346895db39937/html5/thumbnails/30.jpg)
Tetrastarch (Voluven)
MW 130,000 D- DS 0.4
Used for volume therapy
Dose: 50ml/kg/day
![Page 31: Lecture Title: Peri-operative Fluid Therapy and Blood Transfusion Practice](https://reader035.fdocuments.us/reader035/viewer/2022062803/56814674550346895db39937/html5/thumbnails/31.jpg)
MW DS Max doseHetastarch 240,000 0.7 1,500/day
Pentastarch 200,000 0.5 2,500/day
Tetrastarch 130,000 0.4 3,500//day(Voluven)
![Page 32: Lecture Title: Peri-operative Fluid Therapy and Blood Transfusion Practice](https://reader035.fdocuments.us/reader035/viewer/2022062803/56814674550346895db39937/html5/thumbnails/32.jpg)
Crystalloids ColloidsIVVP Poor GoodHemod Stability Transient ProlongInfusate volume Large ModeratePlasma COP Reduced MaintainTissue edema Obvious InsignificAnaphylaxis Non-exist low-modCost Inexpensive Expensive
![Page 33: Lecture Title: Peri-operative Fluid Therapy and Blood Transfusion Practice](https://reader035.fdocuments.us/reader035/viewer/2022062803/56814674550346895db39937/html5/thumbnails/33.jpg)
![Page 34: Lecture Title: Peri-operative Fluid Therapy and Blood Transfusion Practice](https://reader035.fdocuments.us/reader035/viewer/2022062803/56814674550346895db39937/html5/thumbnails/34.jpg)
Crystalloids OR Colloids
ACS protocol for ATLS: replace each ml of blood losswith 3 ml of crystalloid fluid. 3 for 1 rule. Patientresponse:-Rapid-Transient-Non-responsive
![Page 35: Lecture Title: Peri-operative Fluid Therapy and Blood Transfusion Practice](https://reader035.fdocuments.us/reader035/viewer/2022062803/56814674550346895db39937/html5/thumbnails/35.jpg)
Blood Transfusion(up to 30% of blood volume can be treated with crystalloids)
Why?-Improvement of oxygen transport-Restoration of red cell mass-Correction of bleeding caused by platelet dysfunction-Correction of bleeding caused by factor deficiencies
![Page 36: Lecture Title: Peri-operative Fluid Therapy and Blood Transfusion Practice](https://reader035.fdocuments.us/reader035/viewer/2022062803/56814674550346895db39937/html5/thumbnails/36.jpg)
Massive Transfusion (MT)
Definition:
Transfusion of at least one blood volume or 10 units ofblood in a 24 hr period
![Page 37: Lecture Title: Peri-operative Fluid Therapy and Blood Transfusion Practice](https://reader035.fdocuments.us/reader035/viewer/2022062803/56814674550346895db39937/html5/thumbnails/37.jpg)
Pathophysiology of coagulopathy in MT
-Hemodilution
-Hypothermia
-Blood components and alteration of hemostasis
![Page 38: Lecture Title: Peri-operative Fluid Therapy and Blood Transfusion Practice](https://reader035.fdocuments.us/reader035/viewer/2022062803/56814674550346895db39937/html5/thumbnails/38.jpg)
DIC
Type Definition Diagnosis Lab
Biological Hemostatic defect high D-Dimers and DD≥500ug/l
without clinical SS major or minor criteria Plat 50-100,000 of platelet consumption
Clinical Hemostatic defect+He same above+microvasc INR 1.2-1.5
bleeding
Complicated +ischemia +organ failure
![Page 39: Lecture Title: Peri-operative Fluid Therapy and Blood Transfusion Practice](https://reader035.fdocuments.us/reader035/viewer/2022062803/56814674550346895db39937/html5/thumbnails/39.jpg)
Auto-transfusion
Techniques:
-Pre-deposit transfusion
-Intra-operative acute normovolemic hemodilution
-Intra-operative cell salvage
![Page 40: Lecture Title: Peri-operative Fluid Therapy and Blood Transfusion Practice](https://reader035.fdocuments.us/reader035/viewer/2022062803/56814674550346895db39937/html5/thumbnails/40.jpg)
![Page 41: Lecture Title: Peri-operative Fluid Therapy and Blood Transfusion Practice](https://reader035.fdocuments.us/reader035/viewer/2022062803/56814674550346895db39937/html5/thumbnails/41.jpg)
![Page 42: Lecture Title: Peri-operative Fluid Therapy and Blood Transfusion Practice](https://reader035.fdocuments.us/reader035/viewer/2022062803/56814674550346895db39937/html5/thumbnails/42.jpg)
Pre-deposit transfusion
-blood collection begins 3-5 weeks preoperatively-2-4 units stored-Eliminates risk of viral transmission-Reduces risk of immunological reactions-Collection is expensive and time consuming-Only suitable for elective surgery
![Page 43: Lecture Title: Peri-operative Fluid Therapy and Blood Transfusion Practice](https://reader035.fdocuments.us/reader035/viewer/2022062803/56814674550346895db39937/html5/thumbnails/43.jpg)
Intra-operative acute normovolemic hemodilution
-Whole blood removed at start of surgery-1-1.5L can be collected-Blood stored in OR-Re-infused during or after surgery-Cheaper than pre-deposit-Little risk of clerical error-Suitable for elective surgery
![Page 44: Lecture Title: Peri-operative Fluid Therapy and Blood Transfusion Practice](https://reader035.fdocuments.us/reader035/viewer/2022062803/56814674550346895db39937/html5/thumbnails/44.jpg)
Intra-operative cell salvage
-shed blood is collected from surgical field-heparin added-cells washed with saline and concentrated by centrifugation.
-concentrate transfused-large volume could be used-platelets and clotting factors are consumed-suitable for cardiac surgery-contraindicated in contaminated surgical field
![Page 45: Lecture Title: Peri-operative Fluid Therapy and Blood Transfusion Practice](https://reader035.fdocuments.us/reader035/viewer/2022062803/56814674550346895db39937/html5/thumbnails/45.jpg)
FFP-Is plasma removed from a unit of whole blood and frozen at or below –18C within 8hr of collection
-It contains all coagulation factors in normal amounts and is free of red cells, leukocytes and platelets
-It is not a concentrate of clotting factors. One unit is 225ml and must be ABO compatible, Rh not considered
-1ml/kg will raise most clotting factors by 1%.
-Should be used within 24hr after thawing
![Page 46: Lecture Title: Peri-operative Fluid Therapy and Blood Transfusion Practice](https://reader035.fdocuments.us/reader035/viewer/2022062803/56814674550346895db39937/html5/thumbnails/46.jpg)
Cryoprecipitate
-Is low purity concentrate of 3 hemostatic proteins prepared fromdonated whole blood
-A single bag Cryo contains: 100units factor VIII and VWF+150-250mgfibrinogen with XIII and fibronectin
-No compatibilty test required
-Indication: hypo-fibrinogenemia<100mg/dl
![Page 47: Lecture Title: Peri-operative Fluid Therapy and Blood Transfusion Practice](https://reader035.fdocuments.us/reader035/viewer/2022062803/56814674550346895db39937/html5/thumbnails/47.jpg)
Pre-Storage Leuko-reductionDefinition: Is the process used to filter white blood cells from wholeblood before transfusion
WBC removed because they provide no benefit to the recipient and cancarry bacteria and viruses.
Problems with leukocytes:-Fever-Allo-immunization: an immune system reaction that may result in poor transfusion response when the patient is transfused at a later time
![Page 48: Lecture Title: Peri-operative Fluid Therapy and Blood Transfusion Practice](https://reader035.fdocuments.us/reader035/viewer/2022062803/56814674550346895db39937/html5/thumbnails/48.jpg)
Complications of Blood Transfusion
Immune complications:-hemolytic (acute and delayed)-non-hemolytic (febrile, urticaria, anaphylactic, purpura, immune suppression)
Non-Immune complications:-Complications associated with massive blood transfusion: coagulopathy, citrate toxicity, hypothermia, acid-base balance, serum K-Infectious complications: hepatitis, AIDS, other viral agents (CMV,EBV,HTLV), parasites and bacteria..
![Page 49: Lecture Title: Peri-operative Fluid Therapy and Blood Transfusion Practice](https://reader035.fdocuments.us/reader035/viewer/2022062803/56814674550346895db39937/html5/thumbnails/49.jpg)
Reference book and Journal Reference book and Journal referencereference
-American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Practice guidelines for perioperative blood transfusion and adjuvant therapies. Approved October 22, 1995, last amended October 25, 2005. Available at http://www.asahq.org/publicationsAndServices/practiceparam.htm#blood. Accessed January 22, 2006.
- Grocott M et al. Perioperative fluid management and clinical outcomes in adults. Anesthesia Analgesia 2005;100:1093-106
![Page 50: Lecture Title: Peri-operative Fluid Therapy and Blood Transfusion Practice](https://reader035.fdocuments.us/reader035/viewer/2022062803/56814674550346895db39937/html5/thumbnails/50.jpg)
TThank You hank You